Canada markets open in 1 hour 41 minutes

DIAGNOS Inc. (ADK.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
0.1900+0.0100 (+5.56%)
At close: 01:27PM EDT
Full screen
Previous Close0.1800
Open0.1900
Bid0.1850 x 0
Ask0.1900 x 0
Day's Range0.1850 - 0.1950
52 Week Range0.1800 - 0.6500
Volume128,477
Avg. Volume78,760
Market Cap13.133M
Beta (5Y Monthly)0.05
PE Ratio (TTM)N/A
EPS (TTM)-0.0370
Earnings DateOct 27, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • GlobeNewswire

    DIAGNOS Announces a Contract with Farmacias Benavides, a Member of Walgreens Boots Alliance in Mexico

    BROSSARD, Quebec, May 10, 2022 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS”, the “Corporation” or ”we”) (TSX Venture: ADK) (OTCQB: DGNOF) a leader in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence (AI), is pleased to announce the signing of a contract with Farmacias Benavides, a member of Walgreens Boots Alliance in Mexico. “In Farmacias Benavides we are focussed on providing the best health and wellness products for Mexican famil

  • GlobeNewswire

    DIAGNOS Announces the Extension of its Contract with Novo Nordisk for the Follow-up of Diabetic Patients Under Treatment with Drugs Included in its Therapeutic Portfolio

    BROSSARD, Quebec, April 26, 2022 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS”, the “Corporation” or “we”) (TSX Venture: ADK) (OTCQB: DGNOF), a leader in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence (AI), is pleased to announce the extension of its contract for the follow-up of Diabetic patients under treatment with drugs included in its therapeutic portfolio. Novo Nordisk’s therapeutic portfolio offers positive benefits by reduc

  • GlobeNewswire

    DIAGNOS Announces Closing of Private Placement and New Marketing Director

    BROSSARD, Quebec, March 28, 2022 (GLOBE NEWSWIRE) -- DIAGNOS Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF), a leader in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence (AI), announces that it has closed a second and final tranche of a non-brokered private placement (“Private Placement”) of 34 additional units (each a “Unit”) at a price of $10,000 per Unit for gross proceeds of $340,000. Combined with the